Corteva Sees $300M Of Gross Productivity Benefits Across 2027-2029; Corteva Sees More Than $200M Of Net Cost Improvement Across 2027-2029, After Inflation And Tariff Offsets; Residual Inflation And Tariff Impacts Will Be Concentrated Mostly In 2027; Says Its Seed-Treatment Portfolio Is Now About $500M, Vs. About $400M Before Separation